A detailed history of Mesirow Financial Investment Management, Inc. transactions in Vaxart, Inc. stock. As of the latest transaction made, Mesirow Financial Investment Management, Inc. holds 20,000 shares of VXRT stock, worth $19,800. This represents 0.0% of its overall portfolio holdings.

Number of Shares
20,000
Holding current value
$19,800
% of portfolio
0.0%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

BUY
$0.53 - $1.3 $10,600 - $26,000
20,000 New
20,000 $13,000
Q1 2024

Apr 25, 2024

BUY
$0.56 - $1.41 $5,600 - $14,100
10,000 New
10,000 $13,000

Others Institutions Holding VXRT

About Vaxart, Inc.


  • Ticker VXRT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 126,506,000
  • Market Cap $125M
  • Description
  • Vaxart, Inc., a clinical-stage biotechnology company, engages in the discovery and development of oral recombinant protein vaccines based on its proprietary oral vaccine platform. The company's product pipeline includes norovirus vaccine, an oral tablet vaccine, which is in a Phase Ib clinical trial with bivalent oral tablet vaccine for the GI.1...
More about VXRT
Track This Portfolio

Track Mesirow Financial Investment Management, Inc. Portfolio

Follow Mesirow Financial Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Mesirow Financial Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Mesirow Financial Investment Management, Inc. with notifications on news.